Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment

Annals of the Rheumatic Diseases

Volumn 64, Issue 8, 2005, Pages 1137-1140

  Briot, K ^a   Garnero, P ^b   Le Henanff, A ^a   Dougados, M ^a   Roux, C ^a  

^a Département de Rhumatologie ^*  (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; FEMALE; HUMAN; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RADIOIMMUNOASSAY; SPONDYLOARTHROPATHY; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; DENSITOMETRY, X-RAY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPONDYLARTHROPATHIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22244433242     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.028670     Document Type: Article

References (31)

1. DeWys WD, Begg C, Lavin PT, Bandt PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients Eastern Cooperative Oncology Group. Am J Med 1980;69:491-7.
2. Kotler DP, Wang J, Pierson RN. Body composition studies with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255-65.
3. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19:1505-10.
4. Rail LC, Rosen CJ, Dolnikowski G, Hartman WJ, Lundgren N, Abad LW, et al. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor α. Arthritis Rheum 1996;39:1115-24.
5. Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis 1997;56:326-9.
6. Roubenoff R, Rall LC. Humoral mediation of changing body composition during aging and chronic inflammation. Nutr Rev 1993;51:1-11.
7. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol, 1997;36:444-8.
8. Yumet G, Shumate ML, Bryant P, Lin CM, Lang CH, Cooney RN. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis. Am J Physiol Endocrinol Metab 2002;283:472-81.
9. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-56.
10. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 2001;40:882-8.
11. El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999;26:2205-10.
12. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. Am J Clin Nutr 1993;57:605-8.
13. Jensen MD, Kanaley JA, Roust LR, O'Brien PC, Braun JS, Dunn WL, et al. Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc 1993;68:867-73.
14. Allai F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C. Increase in bone mineral density of patients with spondylarthropthy treated with antitumour necrosis factor alpha. Ann Rheum Dis 2003;62:347-9.
15. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093-101.
16. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
17. Costelli P, Carbo N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM, et al. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993;92:2783-9.
18. Zamir O, Hasselgren PO, O'Brien W, Thompson RC, Fischer JE. Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). Ann Surg 1992;216:381-7.
19. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992;127:170-4.
20. Fan J, Char D, Bagby GJ, Gelato MC, Lang CH. Regulation of insulin-like growth factor-1 (IGF-1) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 1995;269:1204-12.
21. Rail LC, Roubenoff R. Body composition, metabolism, and resistance exercise in patients with rheumatoid arthritis. Arthritis Care Res 1996;9:151-6.
22. Marzo-Ortega H, McGonagle D, Haugeberg G, Green MJ, Slewart SP, Emery P. Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Ann Rheum Dis 2003;62:1020-1.
23. Vis M, Wolbink GJ, Lodder MC, Kostense PJ, van de Stady RJ, de Koning MH, et al. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Arthritis Rheum 2003;48:2996-7.
24. Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD. Effects of intranasal 17β-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. J Clin Endocrinol Metab 1999;84:2390-7.
25. Andreassen TT, Oxlund H. Local anabolic effects of growth hormone on intact bone and fracture in rats. Calcif Tissue Int 2003;73:258-64.
26. Woodhouse LJ, Asa SL, Thomas SG, Ezzat S. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1999;84:4570-7.
27. Bouillon R. Growth hormone and bone. Worm Res 1991;36:49-55.
28. Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 1999;14:1622-7.
29. Edelstein SL, Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol 1993;138:160-9.
30. Young D, Hopper JL, Nowson CA, Green RM, Sherwin M, Kaymakci B, et al. Determinants of bone mass in 10-to 26-year-old females: a twin study. J Bone Miner Res 1995;10:558-67.
31. Aloia JF, Vaswani A, Ma R, Plaster E. To what extent is bone mass determined by fat-free or fat mass. Am J Clin Nutr 1995;61:1110-14.